256 related articles for article (PubMed ID: 7535606)
1. Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands.
Le Gros G; Zhang XM; Parsons PG
Melanoma Res; 1994 Dec; 4(6):359-64. PubMed ID: 7535606
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
Cardell LO; Edvinsson L
Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
[TBL] [Abstract][Full Text] [Related]
3. Lack of the specific influence of histamine and histamine H1, H2 and H3 receptor ligands on the serotonin uptake and release in rat blood platelets.
Pawlak D; Malinowska B; Wollny T; Godlewski G; Buczko W
Pol J Pharmacol; 1996; 48(6):615-20. PubMed ID: 9112702
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tyrosinase expression and activity in human melanoma cells via histamine receptors.
McEwan MT; Parsons PG
J Invest Dermatol; 1991 Nov; 97(5):868-73. PubMed ID: 1680932
[TBL] [Abstract][Full Text] [Related]
5. Reduction of DNA synthesis, pigment synthesis, pigmentation gene mRNA and resistance to UVB in human melanoma cells treated with analogues of a histamine (H2) agonist.
Fechner GA; Michel J; Sturm RA; Jacobs JJ; Parsons PG
Biochem Pharmacol; 1994 Jul; 48(1):121-30. PubMed ID: 8043013
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and depigmenting effects of the histamine (H2) agonist dimaprit and its derivatives on human melanoma cells.
Fechner GA; Parsons PG; McEwan MT; Jacobs JJ; Takahashi H
Biochem Pharmacol; 1992 May; 43(10):2083-90. PubMed ID: 1534659
[TBL] [Abstract][Full Text] [Related]
7. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-alpha-methyl-histamine on human H(2) receptors expressed in CHO cells.
Saitoh T; Fukushima Y; Otsuka H; Ishikawa M; Tamai M; Takahashi H; Mori H; Asano T; Anai M; Ishikawa T; Katsube T; Ogawa K; Kajiwara T; Omata M; Ohkawa S
Gut; 2002 Jun; 50(6):786-9. PubMed ID: 12010879
[TBL] [Abstract][Full Text] [Related]
9. Evidence of H3 receptor inhibition by iodoaminopotentidine in the guinea pig ileum.
Hemedah M; Mitchelson FJ; Coupar IM
Life Sci; 1998; 63(15):1371-6. PubMed ID: 9768875
[TBL] [Abstract][Full Text] [Related]
10. Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes.
Yoshida M; Takahashi Y; Inoue S
J Invest Dermatol; 2000 Feb; 114(2):334-42. PubMed ID: 10651995
[TBL] [Abstract][Full Text] [Related]
11. Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells.
Fukushima Y; Ishikawa T; Saitoh T; Tateishi K; Ogihara T; Fujishiro M; Shojima N; Honda M; Kushiyama A; Anai M; Sakoda H; Ono H; Onishi Y; Otsuka H; Katagiri H; Nagai R; Omata M; Asano T
Digestion; 2003; 68(2-3):145-52. PubMed ID: 14671421
[TBL] [Abstract][Full Text] [Related]
12. The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture.
Uçar K
Biochem Biophys Res Commun; 1991 May; 177(1):545-50. PubMed ID: 1904222
[TBL] [Abstract][Full Text] [Related]
13. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
14. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.
Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of R-alpha-methylhistamine, a selective histamine H3 receptor agonist, in rats: lack of involvement of histamine H3 receptors.
Hegde SS; Chan P; Eglen RM
Eur J Pharmacol; 1994 Jan; 251(1):43-51. PubMed ID: 7907986
[TBL] [Abstract][Full Text] [Related]
16. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level.
Naeyaert JM; Eller M; Gordon PR; Park HY; Gilchrest BA
Br J Dermatol; 1991 Oct; 125(4):297-303. PubMed ID: 1720016
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic histamine H2 receptors modulate the sympathetic nerve transmission in the isolated rat vas deferens; no role for H3-receptors.
Poli E; Todorov S; Pozzoli C; Bertaccini G
Agents Actions; 1994 Oct; 42(3-4):95-100. PubMed ID: 7879708
[TBL] [Abstract][Full Text] [Related]
18. Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors.
Smit MJ; Leurs R; Alewijnse AE; Blauw J; Van Nieuw Amerongen GP; Van De Vrede Y; Roovers E; Timmerman H
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6802-7. PubMed ID: 8692899
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
Krielaart MJ; Veenstra DM; van Buuren KJ
Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
